Kathy Whitney

October 2, 2014

VHVI screening brings heart care to young athletes

Vanderbilt Heart and Vascular Institute (VHVI) recently hosted a cardiovascular health screening for participants in a nonprofit organization called the Enplay Foundation, for middle and high school athletes and their adult family members.

By Kathy Whitney
September 18, 2014

These Doctors Mean Business: Med school graduates contributing in non-clinical roles

By Kathy Whitney
September 18, 2014

Heart Institute testing world’s tiniest pacemaker

Vanderbilt Heart and Vascular Institute is participating in a global clinical trial to test the safety and efficacy of the world’s smallest pacemaker.

By Kathy Whitney
September 11, 2014

Nashville Heart Walk hits Vanderbilt campus on Oct. 4

The 2014 Greater Nashville Heart Walk will take place on Vanderbilt’s campus on Saturday, Oct. 4.

By Kathy Whitney
September 4, 2014

Stallworth debuts hemodialysis service for rehab patients

Vanderbilt Stallworth Rehabilitation Hospital (VSRH) is now offering hemodialysis for its patients, eliminating the need to transport them off site for treatment.

By Kathy Whitney
August 21, 2014

Team effort key to ease patient’s rare heart disorder

Vanderbilt employee Drew Casey, 27, was at home when he began to experience shortness of breath. Thinking it might be a panic attack, his wife, Katie, called 911, and an ambulance took Casey to the Emergency Department, where he progressed very suddenly to circulatory failure and shock.

By Kathy Whitney
August 7, 2014

Study tracks new end-stage renal disease therapy

Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease.
By Kathy Whitney
July 10, 2014

AHA grant creates coalition to prevent heart disease, stroke

Vanderbilt University Medical Center is one of four institutions that are part of a new research network aimed at preventing heart disease and stroke, the two leading causes of death in the world.
By Kathy Whitney
June 26, 2014

VU study shows common diabetes drug can slow chronic kidney disease progression

Vanderbilt investigators have demonstrated in two studies that metformin-based treatments delay the onset and progression of chronic kidney disease (CKD) compared with other treatments for diabetes.
By Kathy Whitney
June 19, 2014

Photo: Vanderbilt Heart Town Hall

By Kathy Whitney
May 29, 2014

New center dedicated to kidney disease

Kidney disease is the eighth most common cause of death in the United States and affects more than 20 million people, yet many people don’t know they have kidney disease because it often develops very slowly and with minimal symptoms. For this reason, kidney disease is often referred to as a silent killer.
By Kathy Whitney
May 22, 2014

Classmates unite to create medical scholarships

Whether it’s former classmates or perfect strangers coming together to support a great cause, there is no denying that there is strength in numbers.
By Kathy Whitney
1 … 21 22 23 24 25 … 29